PBM (Psyence Biomedical) FCF Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PBM Psyence Biomedical Ltd PBM
14 GF Score
Price $5.40
! 4 Warning Signs
View Full Analysis

What is Psyence Biomedical FCF Margin %?

Psyence Biomedical PBM +9.64% 14 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates PBM with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 961 Biotechnology companies, Psyence Biomedical ranks worse than 104058.17% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Psyence Biomedical's Free Cash Flow for the six months ended in Mar. 2026 was $-6.11 Mil. Psyence Biomedical's Revenue for the six months ended in Mar. 2026 was $0.00 Mil. Therefore, Psyence Biomedical's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Psyence Biomedical's current FCF Yield % is -39.53%.

The historical rank and industry rank for Psyence Biomedical's FCF Margin % or its related term are showing as below:


PBM's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -77.76
* Ranked among companies with meaningful FCF Margin % only.

Psyence Biomedical FCF Margin % Related Terms

Psyence Biomedical FCF Margin % Historical Data

* Premium members only.

The historical data trend for Psyence Biomedical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Psyence Biomedical FCF Margin % Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PBM vs NRSN, PLUR, CALC: FCF Margin % Comparison

For the Biotechnology subindustry, Psyence Biomedical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psyence Biomedical FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's FCF Margin % falls into.


PBM
14GF Score
Psyence Biomedical Ltd PBM
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Psyence Biomedical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Psyence Biomedical's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-8.643/0
= %

Psyence Biomedical's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-6.114/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Psyence Biomedical (PBM) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Psyence Biomedical and its competitors. According to the industry distribution chart, Psyence Biomedical ranks #999999 out of 961 companies in the Biotechnology industry.
Is Psyence Biomedical's FCF Margin % too high?
Psyence Biomedical's current FCF Margin % is 0.00%. Based on the distribution chart, Psyence Biomedical ranks #999999 out of 961 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Psyence Biomedical has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Psyence Biomedical's FCF Margin % compare to NRSN and PLUR?
According to the Biotechnology industry distribution chart, Psyence Biomedical ranks #999999 out of 961 companies for FCF Margin %. This places Psyence Biomedical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Psyence Biomedical and its competitors. Psyence Biomedical's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Psyence Biomedical stock overvalued right now?
Psyence Biomedical (PBM) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Psyence Biomedical's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Psyence Biomedical (PBM), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Psyence Biomedical Business Description

Address 121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
14GF Score

Get the complete analysis for PBM

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.40
Price